CryptoTradeSignals

0x: NEW DEVELOPMENTS - PROFIT = 36.43% !!!

BITFINEX:ZRXBTC   0x / Bitcoin
Our "Crypto Scalper" Trade Indicator has correctly identified a buy in point on the 1nd of May 2018.

Using this buy in point and selling at today's price, you would have expected to net 36.43% PROFIT!!!

The increase in price may also be explained by positive developments including:

Feb 7: OpenFinance complets the world’s first ever fully compliant security token trade via the 0xProject protocol!

March 24: 0x announces 0x Trade Widget (allows users to instantly buy Ethereum tokens with 0x protocol).

April 5: 0x announces 0x Protocol v2.

April 6: 0x tokens are ablet to be traded ion Abra wallets.

April 19: 0x announces that its protocol enables Compliant peer-to-peer trading allowing for widespread DEX adoption (by meeting KYC and AML 2.71% requirements).

April 26: 0x announces the Bloqboard, the first live Dharma Debt Relayer is launched.

April 26: 0x announces SharkRelay was released live on it mainnet.

April 27: 0x announces Short selling and leveraged long trading coming to decentralized exchanges soon via dydxprotocol

May 2: Radar Relay (facilitates wallet-to-wallet trading using an open order book) using the 0x protocol facilitates $100 million worth of volume during their beta period.

May 2: Rumours released that 0x will be released on Coinbase.

(NEW) May 3: Bambo Relay is released. It is a ERC20 relayer that is built on the 0x protocol. It has the following features:

- Trade directly from your Ledger Wallet
- Night and day mode for the UI
- Trollbox
- The ability to trade any ERC20 compatible token
- Standard Relayer API endpoints
- Free trades during the beta

(NEW) May 3: Radar Relay (which uses the 0x token) is available in Chinese and Korea.

The general uptrend in the crypto markets as well as the positive developments above have caused an increase in demand for the 0x token which have forced up prices.

GO TO: www.cryptotradesignals.org for access to ALL OUR TRADING INDICATORS + SET UP GUIDE!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.